Panelists discuss how accurate risk stratification using clinical and molecular prognostic tools like DIPSS, MIPSS70, and GIPSS guides personalized treatment decisions in myelofibrosis, ranging from ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Gastrointestinal (GI) cancers represent a significant global health burden with complex biological behaviors and ...

Cullinan Therapeutics (CGEM) announced that the European Medicines Agency, EMA, approved the Company’s Clinical Trial Application, CTA, for ...

has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical trial of ITOP1, the company's lead 'off-the-shelf' cancer vaccine. ITOP1 is a precision cancer ...